Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

-1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.

Sóter MO, Gomes KB, Fernandes AP, Carvalho Md, Pinheiro PS, Bosco AA, Silva DD, Sousa MO.

Mol Biol Rep. 2012 Jul;39(7):7541-8. doi: 10.1007/s11033-012-1588-x. Epub 2012 Feb 19.

PMID:
22350263
3.

Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke.

Can Demirdöğen B, Şahin E, Türkanoğlu Özçelik A, Bek S, Demirkaya Ş, Adali O.

Mol Biol Rep. 2012 Dec;39(12):10459-68. doi: 10.1007/s11033-012-1926-z. Epub 2012 Oct 13.

PMID:
23065249
4.

The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.

Dorfmeister B, Cooper JA, Stephens JW, Ireland H, Hurel SJ, Humphries SE, Talmud PJ.

Biochim Biophys Acta. 2007 Mar;1772(3):355-63. Epub 2006 Dec 5.

5.

The polymorphism -1131T>C in apolipoprotein A5 gene is associated with dyslipidemia in Brazilian subjects.

Ferreira CN, Carvalho MG, Fernandes AP, Santos IR, Rodrigues KF, Lana AM, Almeida CR, Loures-Vale AA, Gomes KB, Sousa MO.

Gene. 2013 Mar 1;516(1):171-5. doi: 10.1016/j.gene.2012.12.016. Epub 2012 Dec 22.

PMID:
23266809
6.

[Association of apolipoprotein A5 gene -1131T/C polymorphism with serum lipids and carotid intima-media thickness in patients with type 2 diabetes mellitus].

Qiao Y, Liu R, Tian HM, Liu Y, Qiang O, Liu BW.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Nov;39(6):965-8, 999. Chinese.

PMID:
19253837
7.

Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.

Pi Y, Zhang L, Yang Q, Li B, Guo L, Fang C, Gao C, Wang J, Xiang J, Li J.

Cerebrovasc Dis. 2012;33(6):558-65. doi: 10.1159/000338781. Epub 2012 Jun 8.

PMID:
22688093
8.

Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients.

Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, Perrot L, Le Coquil E, Sassolas A, Moulin P, Marcais C.

Clin Chim Acta. 2008 Aug;394(1-2):99-103. doi: 10.1016/j.cca.2008.04.013. Epub 2008 Apr 27.

PMID:
18468520
9.
10.

Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.

Brito DD, Fernandes AP, Gomes KB, Coelho FF, Cruz NG, Sabino AP, Cardoso JE, Figueiredo-Filho PP, Diamante R, Norton CR, Sousa MO.

Mol Biol Rep. 2011 Oct;38(7):4381-8. doi: 10.1007/s11033-010-0565-5. Epub 2010 Dec 4.

PMID:
21132386
11.

Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.

Chandak GR, Ward KJ, Yajnik CS, Pandit AN, Bavdekar A, Joglekar CV, Fall CH, Mohankrishna P, Wilkin TJ, Metcalf BS, Weedon MN, Frayling TM, Hattersley AT.

BMC Med Genet. 2006 Oct 10;7:76.

12.

Association of apolipoprotein A5 gene polymorphisms and serum lipid levels.

Li YY, Yin RX, Lai CQ, Li M, Long XJ, Li KL, Liu WY, Zhang L, Wu JZ.

Nutr Metab Cardiovasc Dis. 2011 Dec;21(12):947-56. doi: 10.1016/j.numecd.2010.04.004. Epub 2010 Aug 13.

PMID:
20708914
13.

Contribution of APOA5-1131C allele to the increased susceptibility of diabetes mellitus in association with higher triglyceride in Korean women.

Lee KH, Kim OY, Lim HH, Lee YJ, Jang Y, Lee JH.

Metabolism. 2010 Nov;59(11):1583-90. doi: 10.1016/j.metabol.2010.02.008. Epub 2010 Mar 29.

PMID:
20303129
14.

Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.

Kim JY, Kim OY, Paik JK, Lee SH, Lee JH.

J Clin Lipidol. 2013 Mar-Apr;7(2):94-101. doi: 10.1016/j.jacl.2012.06.002. Epub 2012 Jun 28.

PMID:
23415427
15.

The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.

Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Guardiola M, Heras M, Masana L.

Nutr Metab Cardiovasc Dis. 2010 May;20(4):243-8. doi: 10.1016/j.numecd.2009.04.003. Epub 2009 Sep 17.

PMID:
19765959
16.

Association of APOA5 -1131T>C polymorphism and serum lipid levels in patients with type 2 diabetes.

Celap I, Simundic AM, Nikolac N, Kackov S, Katalinic D.

DNA Cell Biol. 2013 Oct;32(10):589-93. doi: 10.1089/dna.2013.2099. Epub 2013 Aug 6.

PMID:
23919616
17.

Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.

Smith RC, Segman RH, Golcer-Dubner T, Pavlov V, Lerer B.

Pharmacogenomics J. 2008 Jun;8(3):228-36. Epub 2007 Aug 28.

PMID:
17726453
18.

Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.

Hiramatsu M, Oguri M, Kato K, Horibe H, Fujimaki T, Watanabe S, Satoh K, Aoyagi Y, Tanaka M, Shin DJ, Lee JH, Jang Y, Yamada Y.

Int J Mol Med. 2012 Jul;30(1):185-92. doi: 10.3892/ijmm.2012.976. Epub 2012 Apr 20.

PMID:
22576629
19.

The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.

Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, Lee SH, Shin DJ, Ordovas JM, Lee JH.

Clin Chim Acta. 2009 Apr;402(1-2):83-7. doi: 10.1016/j.cca.2008.12.024. Epub 2008 Dec 31.

20.

Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.

van der Vleuten GM, Isaacs A, Zeng WW, ter Avest E, Talmud PJ, Dallinga-Thie GM, van Duijn CM, Stalenhoef AF, de Graaf J.

Biochim Biophys Acta. 2007 Jan;1772(1):81-8. Epub 2006 Oct 26.

Items per page

Supplemental Content

Write to the Help Desk